Navigation Links
Raven Announces Phase 1 Clinical Trial Results of RAV12 Therapeutic Antibody for Treatment of Adenocarcinomas
Date:11/19/2007

on day 42.

Study Results

RAV12 was moderately well-tolerated with fractionated dosing that allowed delivery of an "effective dose" (i.e. 1.5 mg/kg total dose over one week time) as 0.75 mg/kg twice weekly. The two primary side effects observed were Infusion-associated abdominal discomfort and diarrhea, and elevated liver function tests. Both side effects appear related to CMax as they tended to appear early on after dosing and tended to resolve rapidly after dosing, and were ameliorated by fractionated dosing.

Treatment with RAV12 demonstrated preliminary evidence of anti-tumor activity. One patient with refractory colorectal cancer experienced a partial remission with time to progression exceeding 8 months and one patient with advanced pancreatic cancer had a > 50% reduction in the relevant tumor marker, CA19-9 and experienced disease stability for more than five months.

As a result of these findings, future development of RAV12 both as single agent and in combination with chemotherapy is planned for 2008. The recommended dose and schedule for Phase 2 clinical study of RAV12 is 0.75 mg/kg twice weekly.

About RAV12

RAV12 is a novel, chimeric monoclonal antibody which is directed against a primate-specific glycotope (sugar structure) that is widely displayed on the surfaces of tumor cells, particularly those of gastrointestinal origin (gastroesophageal, pancreatic, colorectal cancers). Preclinical studies have demonstrated that RAV12 may kill tumor cells in a number of ways: first, the antibody is directly cytotoxic to a human colon cancer cell line in vitro through induction of oncotic cell death, a form of cell death characterized by cell and organelle swelling and loss of membrane integrity; second, the antibody mediates antibody-dependent cellular cytotoxicity; third, the antibody mediates complement dependent cell killing; and finally, the antibody alters cellular signaling required for cell survival. RAV12 is highly efficacio
'/>"/>

SOURCE Raven biotechnologies, inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... WILMINGTON, Del. , March 30, 2015  Rigrodsky & ... Auspex Pharmaceuticals, Inc. (NASDAQ GM: ASPX )? , ... 30, 2015? , Do you think the proposed buyout ... discuss your rights? Rigrodsky & Long, ... against the board of directors of Auspex Pharmaceuticals, Inc. ("Auspex" ...
(Date:3/30/2015)... 30, 2015  MedAptus® today announced the launch ... simplify pre-care needs for busy inpatient provider teams. ... assign patients to hospitalists or other rounding providers ... other requirements such as ensuring patient safety, proper ... In an increasingly ...
(Date:3/30/2015)... -- Edelberg & Associates (EA) and ScribeAmerica today are ... coding software platform designed to engage and successfully ... at the point of care.  In a significant ... successfully built, deployed and tested a new proprietary ... medical coder that can radically improve natural latencies ...
Breaking Medicine Technology:AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 2Edelberg & Associates and ScribeAmerica Partner to Launch Healthcare Industry's First Ever Real-time Medical Coding Solution 3
(Date:3/30/2015)... Textile Exchange, a global nonprofit dedicated to ... the latest version of its Responsible Down Standard ... be applied to any waterfowl-based supply chain to help ... product. The goal of the RDS is to recognize ... enable traceability so that products can be labeled accurately ...
(Date:3/30/2015)... Pearland, TX (PRWEB) March 30, 2015 ... trip to MedX Pharmacy. The staff of pharmacists is ... skin care issues like acne, eczema and other conditions. ... collaborate with a patient’s dermatologist and/or PCP to tackle ... compounding pharmacy, MedX Pharmacy has employed specialty-trained pharmacists who ...
(Date:3/30/2015)... BC (PRWEB) March 30, 2015 Vancouver ... announced that the majority of cases taken up by ... This means that the lawyers help protect the interests ... the tedious court process. The announcement comes across as ... primary job is to provide convenience to their client, ...
(Date:3/30/2015)... Tel-Aviv – March 30, 2015 - ... the closing of $12.5 million in new financing led ... Group. The funding will further GlassesUSA's aggressive business growth ... the growing global market of online eyewear, both B2C ... CEO Daniel Rothman, COO Eldad Rothman, and CTO Roy ...
(Date:3/30/2015)... PHILADELPHIA, Pa. (PRWEB) March 30, 2015 ... today the Halal certification for all current Epax® ... omega-3 facility in Ålesund, Norway. The certification ensures ... fully comply with the Islamic religious regulations for ... another step in FMC’s efforts to further advance ...
Breaking Medicine News(10 mins):Health News:Responsible Down Standard 2.0 Released 2Health News:Responsible Down Standard 2.0 Released 3Health News:MedX Pharmacy Offers Skin Care Tips 2Health News:Jiwa Law Corporation States That Majority of Their Cases Get Settled Before Trial 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 2Health News:GlassesUSA.com Raises $12.5 Million Growth Round Led By Viola Private Equity 3Health News:FMC Health and Nutrition Announces Halal Certification for Epax® Brand Omega-3 Ingredients 2
... , LAS VEGAS, July 13 /PRNewswire/ -- ... welcomes its first patients today, opening the doors to an architectural ... , The Cleveland Clinic Lou Ruvo ... the research, early detection and treatment of neurological diseases, including Alzheimer,s, Huntington,s, Parkinson,s ...
... LEXINGTON, Ky., July 13 VirtualHealth Technologies, Inc. (OTC ... LLC has entered into a preliminary agreement with DRM Security ... and data delivery platform that will change the way healthcare ... President, "CIFRA will finally give healthcare providers the much needed ...
... care costs in Idaho continue to rise at a rate ... near retirement. As a leader in the long term care ... help people proactively plan for their future. Now, AARP(R) members ... program designed to simplify the process of purchasing affordable long ...
... By diversifying its customer base with the assistance ... Tool Company , has landed a three-year, multimillion-dollar ... metalworking products and industrial supplies, formerly was focused ... of its customer base. , , "The automotive ...
... clozapine might have saved thousands of lives, researchers say ... of schizophrenia patients worldwide may have died because of ... antipsychotic drug clozapine, a new study suggests. , Finnish ... death rate compared to other antipsychotics. , For this ...
... to feature keynote speech from U.S. Army Surgeon General and ... and caregivers , , SAN ANTONIO, July 13 ... of research addressing trauma injury in the United States, will ... on trauma research and care in the nation -- on ...
Cached Medicine News:Health News:Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business 2Health News:Cleveland Clinic Lou Ruvo Center for Brain Health Opens for Business 3Health News:Secure eHealth and DRM Security Partner to Provide Most Secure Healthcare Network Available 2Health News:Secure eHealth and DRM Security Partner to Provide Most Secure Healthcare Network Available 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Idaho AARP Members 2Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Idaho AARP Members 3Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Idaho AARP Members 4Health News:Genworth Financial Simplifies the Process of Purchasing Affordable Long Term Care Insurance for Idaho AARP Members 5Health News:Minority Business Accelerator 2.5+ Client Strong Tool Lands Multimillion Dollar Deal With GE Healthcare 2Health News:Minority Business Accelerator 2.5+ Client Strong Tool Lands Multimillion Dollar Deal With GE Healthcare 3Health News:Minority Business Accelerator 2.5+ Client Strong Tool Lands Multimillion Dollar Deal With GE Healthcare 4Health News:Schizophrenia Drug Got Bad Rap 2Health News:National Trauma Institute Announces 15th Annual Trauma Symposium in San Antonio, August 31-September 1 2
Inquire...
... injectable implant that contains microparticles ... biodegradable, synthetic polymer from the ... prior to use by the ... Injection, USP (SWFI) to form ...
Minimizes imperfections and reduces the visible appearance of cellulite and stretch marks. This formula refines uneven skin texture and improves skin firmness and elasticity to leave you with skin yo...
... This new Suction Massage System has been ... areas, such as thighs, buttocks and hips. ... the lymph system, mobilizing excess fluids in ... Initially, we recommend using CELLUSSAGE daily, for ...
Medicine Products: